Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (367)	8/12/1999 3:06:00 PM
From: scaram(o)uche	of 3044

Thursday August 12, 2:45 pm Eastern Time Company Press Release SOURCE: Millennium Pharmaceuticals, Inc. Millennium Delivers Two Cancer Drug Candidate Genes to Eli Lilly - Delivery of Candidate Genes in Prostate Cancer and Drug Resistance Trigger Milestone Payments - CAMBRIDGE, Mass., Aug. 12 /PRNewswire/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news) today announced that one of its partners in oncology, Eli Lilly and Company (NYSE: LLY - news), has accepted two candidate genes for use in the development of new small-molecule cancer therapeutics. These achievements trigger two undisclosed milestone payments from Lilly to Millennium. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next